Updates on Guidelines in the Management of Patients with T2D and Cardiovascular Disease: Implications from CVOTs on Practice Recommendations
Date: June 18, 3 p.m. ET
Get up to date on evidence from the latest landmark cardiovascular outcome trials, and catch up on updated guidelines to help appropriately individualize the management of patients with T2D. Plus, understand new treatment pathways based on CV risk assessment of patients with T2D, and recognize the need to manage CV risk factors within the paradigm of the overall management of T2D and associated macrovascular complications.
Brought to you in partnership with